By Dean Seal
Shares of Sharps Technology jumped after the company said it has initiated a second shipment from its first commercial order of SoloGard syringes.
The stock was up 13% at $5.68 in midday trading. Shares have more than doubled since the start of the year.
The medical device and pharmaceutical-packaging company also said Wednesday that it is installing new molding and automation systems in preparation for a production ramp-up in the second half of the year.
Sharps is executing a $400,000 purchase order from June 4 for a five-year supply of up to 500 million SoloGard syringes.
The sale is the company's first pivot into revenue-generating commercial operations.
Write to Dean Seal at dean.seal@wsj.com
(END) Dow Jones Newswires
Sharps shares have fallen 99% since the start of the year. "Sharps Technology Shares Climb on Latest SoloGard Shipments," at 12:15 p.m. ET, incorrectly said the company's stock has more than doubled.
(END) Dow Jones Newswires
June 18, 2025 12:33 ET (16:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.